Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Prollenium Medical Technologies Inc.
With
Symbio, LLC
This is a multicenter, open-label clinical study of retreatment of subjects seeking lip augmentation who received treatment with either PN40082 or Restylane Silk in prior Protocol PRO 2018-02 (NCT04032977). Subjects meeting the inclusion/exclusion criteria will receive a single additional treatment with PN40082
Age
21–any
Sex
ALL
Healthy volunteers
Accepted
You may not be if
2. If female and of childbearing potential, a negative urine pregnancy test at Visit 1/Day 1 and the subject agrees to use adequate contraception during the study period
3. Willing to give written informed consent
1\. Women who are pregnant, lactating, or planning a pregnancy
Clareo Health | A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation
